Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Not all A1Cs are created equal.
The insurance company UnitedHealthcare (United) is starting a new health care plan to help people better manage diabetes and control employers' increasing insurance...
(S)he said what?!?
Recently, the FDA released a statement on Byetta (Amylin/Lilly’s exenatide) that updated several warnings for the drug as well as expanded its usage. The warnings...
Sanofi-aventis gives us an early preview of its new GoMeals application for the iPhone and iPod Touch.
Who Will Manage American Patients with Diabetes in the Near Future? A Grim Prognosis for the US.
SEEKING Accord on ACCORD
You might have already encountered monofilaments before if your diabetes health care provider is meticulous about screening for peripheral neuropathy, a complication of...
Kelly weighs in on this year's American Diabetes Association scientific sessions and the recent scare over Lantus and cancer.
Education and compassion all around: The 36th Annual Meeting of the American Association of Diabetes Educators.
For anyone interested in continuous glucose monitoring, you now have a third option in addition to the DexCom SEVEN and the Medtronic Guardian or Paradigm. The Abbott...
On June 2, Medtronic hosted its annual “analyst day,” hosting researchers who come to hear news about the company. These days are webcast, and we were interested to hear...
A blogger’s journey into the Twitter-verse.
In late January, the FDA granted approval to two new combination therapies for the treatment of type 2 diabetes – Merck’s Janumet XR and Eli Lilly/Boehringer Ingelheim’s...
It’s often a challenge to figure out the carbohydrate content of different recipes. A new website, My Food Advisor , might be of help. It’s an online nutrition tool...
You want a resolution?
Novo Nordisk is developing a new variation of NovoPen with modifications specifically for children. Dubbed the NovoPen Echo, which will replace the NovoPen Junior, the...
The Look AHEAD trial examines the effect of lifestyle intervention on obesity and type 2 diabetes.
Diabetes and Depression
EASD ’08: The Best of Rome

Pages